In agreement with the above data showing PRL/PRLR as favorable markers of tumor differentiation and suppressors of tumorigenesis, other groups have demonstrated that expression/activation of the PRL effector molecule-Stat5a in breast cancer promotes adhesion and inhibits invasion of breast cancer cells (90). This evidence concerns the gene STAT5A and breast cancer.